Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors
Clinical trial NCT07656116 · RECRUITING
Trial details
- NCT number
- NCT07656116
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-29
- Primary completion
- 2027-01-31
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.